Nearly 30 years of technological accumulation! Qing Shadow Huakang completed 10 million yuan pre-A round financing, leading the cerebrovascular precision image track.

Guide: Mint Angel Fund lead investment, enlightenment star venture capital and investment, Qing Shadow Huakang into active sales.
, a leader in high-resolution magnetic resonance vascular wall imaging technology, Beijing Qing shadow Huakang Technology Co., Ltd. (hereinafter referred to as "Tsinghua Huakang") recently announced the completion of 10 million yuan pre-A round of financing.
this round of financing led by the Mint Angel Fund, Inspiring Star Ventures and Investment.
it is understood that the current round of financing will be used mainly for two aspects.
, Tsinghua Will continue to strengthen product development, looking for more solutions.
, on the other hand, Tsinghua Will turn passive sales into active, further broaden sales channels.
Jian Hou, partner of the Mint Angel Fund, shared the investment logic: "The first step in precision medicine is precision diagnosis, which requires a strong technical background to support it.
such as high-resolution magnetic resonance cerebrovascular imaging requires cross-cutting medical knowledge.
Qing Shadow Huakang happens to have such conditions.
" 2016, Tsinghua University and industry experts jointly launched the establishment of Tsinghua Shadow Huakang, Tsinghua University Biomedical Imaging Research Center research results into products, for cerebrovascular disease patients to provide high-resolution magnetic resonance tube wall imaging solutions.
Tsinghua University team in this field has nearly 30 years of technology development, pathological verification, clinical trials and data accumulation foundation, so that Qing Shadow Huakang in high-resolution magnetic resonance technology in the world's leading.
since its inception, Qing Shadow Huakang has been certified by Beijing high-tech enterprises and Zhongguancun high-tech enterprises, access to a number of inventions and utility model patents.
products have been sold to more than 100 hospitals with the advantages of cerebrovascular diseases, to help promote hospital research and clinical work.
when artificial intelligence medical circle into the second half, Qing Shadow Huakang can be refinanced in the cold winter of capital? In an exclusive interview with Dr. Li Rui, founder of Qing Shadow Huakang, and Dr. Hou Jian, partner of Mint Angel Fund, arterial network analyzes the reasons why Qing Shadow Huakang is favored by capital from many angles.
precise positioning to fill the current cerebrovascular imaging gap, as the famous saying in "Forrest Gump", "Life is like a box of chocolates, you never know what the next piece will taste like."
" cerebrovascular disease took years to accumulate, but the outbreak took only a moment, and it surprised us far more than the chocolate you never knew what it would taste like.
2.5 million (new cases/year), 1.6 million (deaths/year), 12 seconds (incidence rate), 21 seconds (rate of death), 40 billion (medical expenses/year), are the data presented in China's cerebrovascular disease, the worst-hit area, cerebrovascular disease has become the main cause of death in human beings.
, how to accurately diagnose cerebrovascular disease by imaging has become an urgent clinical problem.
Imaging techniques such as cervical arterial ultrasound, transcranial doppler (TCD), magnetic resonance cerebrovascular imaging (MRA), CT angiography (CTA) and digital angiography (DSA) are routinely used to diagnose cerebrovascular disease.
But there are six pain points in these technologies: 1. Focus only on the tube cavity, no tube wall lesions (plaque morphology, composition, function) information 2. Image quality can not be guaranteed 3. Lack of standard imaging scheme 4. Lack of identification criteria for plaque composition and fragile plaque 5. Large amount of image data Processing difficulties 6. Clinical understanding of tube wall imaging is insufficient and clinical application still has the space to enhance the six pain points directly map the value of stroke precision imaging in clinical applications, high-resolution magnetic resonance vascular wall imaging program is undoubtedly for the clinical provision of cerebrovascular disease accurate diagnosis, treatment decision-making, prognostic evaluation of a sharp weapon.
Qing Shadow Huakang integrates high-resolution magnetic resonance imaging technology, professional imaging sequences, dedicated high signal-to-noise ratio imaging coils, artificial intelligence reading algorithms, and imaging workstations to form a complete solution.
provide hospitals with a one-stop, accurate imaging solution from imaging to reporting, making it easier and faster to standardize the clinical application of high-resolution magnetic resonance.
the application of high-resolution magnetic resonance vascular wall imaging in cerebrovascular disease is steady, with three advantages to complete the circle "innovation ability, self-hema production capacity, resources are our three major advantages to obtain financing."
," said Dr. Li Rui, founder of Tsinghua Huakang.
these three advantages, but also qing shadow Huakang favored by the capital of the three factors.
Advantage 1: Innovation.
Qing shadow Huakang has the innovation ability of the whole chain from imaging methods to clinical applications, not only in new hardware, new imaging methods and new image processing algorithms, but also in the ability to innovatively apply these technologies to different clinical applications and find evidence-based medical evidence, which is ultimately written into clinical guidelines.
these innovation capabilities are the cornerstone of the development of Tsinghua Health.
advantage 2: hemaging ability.
Qing Shadow Huakang development of technology are clinical-oriented, and ultimately applied to the clinical, from the clinical to the clinical, forming a complete closed loop, for its own blood-forming capacity, which is the enterprise can open more than 100 hospitals and establish cooperation of important factors.
addition, Tsinghua Also with Philips, Siemens, United Pictures and other manufacturers, fully compatible with domestic and foreign mainstream magnetic resonance manufacturers 1.5T, 3.0T series of equipment.
Advantage 3: Resources.
Qing Shadow Huakang in the early days of the establishment of relying on Tsinghua University Biomedical Imaging Research Center has accumulated a large number of resources, including cooperation with a number of medical imaging technology research and development institutions, more than 100 hospitals of scientific research and clinical cooperation, large-scale medical imaging manufacturers, medical examination institutions and third-party imaging center cooperation, emerging medical imaging data and artificial intelligence companies, such as cooperation.
makes Qing Shadow Huakang in technology research and development, clinical verification and business model has a broad space for development.
to dig deep into the huge market behind precision imaging, as Dr. Li Rui has said, effective treatment of cerebrovascular disease can only be achieved by accurately determining the cause.
Li Rui, speaks of the current market demand for precision imaging and the huge market behind it.
, partner of the Mint Angel Fund, told Arterial.com: "I think Qing Shadow Huakang is a potential leader in the domestic medical imaging segment.
Qing Shadow Huakang's products can improve the quality and speed of high-resolution magnetic imaging, improve the patient experience, efficient use of medical resources, and more importantly, it can tap deep information on cerebrovascular diseases to meet the needs of clinical precision diagnosis and treatment.
, scientists start their own businesses, enabling companies to have strong research and development genes.
, Qing Shadow Huakang has the opportunity to integrate the scientific research achievements of first-class hospitals, including Tsinghua Biomedical Imaging Center.
Rui, founder of Qing Shadow Huakang, said: "At present, Qing Shadow Huakang has completed a high-resolution vascular wall image screening program, accurate 4D blood flow imaging solutions.
will further advance the heart, nerve, animal precision imaging solutions to the ground.
company will gradually improve the sales network, from a single 2B sales to explore a more diversified business model.
believes that Qing Shadow Huakang's advanced clinical solutions will bring disruptive changes to the clinical practice of medical imaging, producing tremendous economic and social value.
founded in 2015, the Mint Angel Fund is China's first Pharmaceutical Health Angel Investment Fund focused on early-stage innovation and research and development companies around the world, dedicated to creating China's best start-up biotech project discoverers, incubators and technology transformation project incubators. The
Fund's team of senior investors, together with world-class scientists, entrepreneurs and entrepreneurs, focuses on cutting-edge life science and technology urgently needed in the Chinese market, as well as research and development of new drugs for tumors, autoimmunity and anti-infective drugs with new target mechanisms, as well as layout of precision medical innovation technology solutions such as early disease screening and molecular imaging, and helping to increase the success rate and development speed of enterprises through a deep understanding of the path and cycle of technological transformation.
about Enlightenment Star Ventures Beijing's most knowledgeable entrepreneurial investment brand. Founded in 2014 and headquartered in Beijing,
Inspire Star Ventures focuses on early investments in high-tech, high-growth start-ups, TMT, integrated circuits, big data, AI artificial intelligence, 5G communications, IOT Internet of Things, energy conservation and environmental protection, new energy, new materials, big health, advanced manufacturing, education, enterprise services, and big consumption.
Investment team, relying on 24 years of incubation and investment experience, is gradually improving the financialization, specialization, internationalization, networking, clustering of strategic layout, in the management fund covers angel mother funds, market-oriented funds, incubator funds, fund management scale of more than 1 billion, aimed at helping to build innovative and entrepreneurial services of the advantages of resources, to create an ecological system of innovation and entrepreneurship.
.